Opaleye Management Inc.: 13F holdings
CIK 15958552026Q2
| Positions | 58 |
|---|
| Reported value | $1.1bn |
|---|
| Filed | 2026-08-14 |
|---|
Change since last quarter
| Positions | 58 (+4 vs prior quarter) |
|---|
| Reported value | $1.1bn (+45.4%) |
|---|
Top 10 holdings
| Security | Shares | Value | Weight |
|---|
| LQDA LIQUIDIA CORPORATION | 2,447,500 | $195.1m | 17.7% |
| ETON ETON PHARMACEUTICALS INC | 2,860,000 | $103.5m | 9.4% |
| HROW HARROW INC | 2,400,000 | $101.9m | 9.2% |
| IRON DISC MEDICINE INC | 855,000 | $62.5m | 5.7% |
| UROGEN PHARMA LTD | 1,439,996 | $53.0m | 4.8% |
| APOGEE THERAPEUTICS INC | 390,000 | $51.8m | 4.7% |
| MEIRAGTX HLDGS PLC | 3,550,000 | $48.0m | 4.3% |
| SOL-GEL TECHNOLOGIES LTD | 500,000 | $37.1m | 3.4% |
| RZLT REZOLUTE INC | 6,300,000 | $32.8m | 3.0% |
| TGTX TG THERAPEUTICS INC | 535,000 | $29.4m | 2.7% |
Get the full book
import finzdata as yf
yf.Client().manager_holdings(cik="1595855")
Every position, quarter by quarter since 2013, with adds, trims and exits, on the look-back bundles.
Get a free API keySee history bundlesDownload free samples